Dicerna Pharmaceuticals' Series C Round

Dicerna Pharmaceuticals raised a round of funding on August 01, 2013.

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' Series C Round: